Patisiran in Patients with Transthyretin Cardiac Amyloidosis. Reply

N Engl J Med. 2024 Jan 18;390(3):286-287. doi: 10.1056/NEJMc2313408.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyloid Neuropathies, Familial* / complications
  • Amyloid Neuropathies, Familial* / therapy
  • Humans
  • Prealbumin* / genetics
  • RNA, Small Interfering / adverse effects

Substances

  • patisiran
  • Prealbumin
  • RNA, Small Interfering